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Abstract In contrast to methicillin-resistant Staphylococ-
cus aureus, little is known of the distribution of spa types
among methicillin-susceptible S. aureus (MSSA). We have
analyzed 101 nonrepetitive invasive MSSA isolates from
infected patients, consecutively isolated during 14 months
between 2006 and 2007 at University Hospital Basel. They
were genetically characterized according to S. aureus
protein A (spa) types and important virulence-associated
genes. Sixty-five different spa types corresponding to nine
different spa clonal complexes were observed. Analysis of
different virulence genes showed a frequency of 17% for
toxic-shock syndrome toxin and 5% for exfoliative toxin D.
In conclusion, spa typing revealed a great genetic diversity
without predominant spa type, not providing evidence for
clonal spreading.
Report
Staphylococcus aureus is an important human pathogen and
is isolated in up to 25% of nosocomial infections. S. aureus
bacteraemia is associated with substantial excess morbidity
and mortality worldwide [1]. A recent study from the
United States showed a predominance of one clonal
complex (ST8) among methicillin-susceptible S. aureus
(MSSA) strains, whereas the remaining strains were
genotypically heterogeneous [2]. Strain typing is an
established tool for surveillance and determination of strain
relatedness. Sequence-based methods such as protein A
gene (spa) strain typing offer the opportunity of reproduc-
ible and comparable results and have been successfully
used in epidemiological studies [3, 4]. To date, relatively
little data exist on spa types and the molecular epidemiol-
ogy of invasive MSSA strains in contrast to methicillin-
resistant S. aureus (MRSA). In this study, our goal was to
assess the frequency of circulating invasive MSSA spa
types isolated from primarily sterile sites in patients at
University Hospital Basel (UHBS), Switzerland, and to
detect virulence associated genes such as Panton-Valentine
leukocidin (PVL), toxic shock syndrome toxin (tst),
exfoliative toxin A, B, and D (eta, etb, etd).
As standard operating procedure, invasive MSSA iso-
lates from primarily sterile sites (cerebro-spinal fluid, sterile
body fluids, biopsies, blood cultures) are routinely saved at
−70°C at our laboratory. The isolates were identified as S.
aureus on the basis of positive catalase, clumping factor
(Slidex StaphPlus, bioMérieux, Marcy l'Etoile, France), and
aurease (RAPIDECstaph, bioMérieux). Only one isolate per
patient was included. DNA was extracted with LC
MagnaPure system (Roche Diagnostics, Rotkreuz, Switzer-
land) according to manufacturer’s instruction. The spa gene
was amplified using primers spa-1113f and spa-1514r and
sequencing was performed as previously described [4].
Sequences were analyzed with Ridom StaphType software
version 1.4 (Ridom GmbH, Würzburg, Germany). Cluster-
ing analysis into spa clonal complexes (spa-CC) was done
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using default parameters (spa types are clustered if cost is
less than or equal to 6 and spa types shorter than 5 repeats
are excluded). PVL, tst, eta, etb, and etd genes were
detected by PCR as described elsewhere [5–7]. Amplifica-
tion of the 16S rRNA gene was used to confirm absence of
PCR inhibitors. PCR products were visualized by electro-
phoresis on ethidium bromide-stained 3% agarose gels.
Antibiotic susceptibility was tested applying a microbroth
dilution procedure (MERLIN Diagnostika, Bornheim-Her-
sel, Germany) and interpreted in accordance with the
Clinical and Laboratory Standards Institute (http://www.
clsi.org).
A total of 105 patients with MSSA infection during a 14-
month period in 2006–2007 were recorded. Isolates of 101
patients were analyzed; four isolates were not available.
The median age of patients was 61 years (interquartile
range 45–74) with 63.4% being males. The highest
proportions of MSSA strains were isolated from the
surgical department (42%), emergency department (31%),
internal medicine (11%), and intensive care units (10%).
Blood culture was the most common body site; the same
organism was isolated from another source in 11.2% (9
isolates; not included to avoid double counting). Specimens
from joint, bone, and skin/soft tissue each accounted for
5.9% (6 isolates). A total of 65 different spa types
corresponding to nine different spa-CC were observed
(Table 1), and 51 strains had a unique spa type. Eleven
newly recognized spa types were found which have
never been deposited before in the spa database (http://
www.spaserver.ridom.de). The ten most frequent spa types
Table 1 Distribution of 101 invasive methicillin-susceptible S. aureus (MSSA) strains by spa clonal complex (spa-CC), presence of virulence-
associated determinants, and antibiotic resistance profile
Spa-CC Spa Type Frequency PVL etd tst eta/etb Penicillin R Clarithromycin R Quinolone Rb Site of Isolation
Blood Other than
blood
n n n n n n (%) n (%) n (%) n n
CC084/085 t084 (8), t085 (1), t091 (1),
t094 (1), t254 (1), t279 (1),
t346 (2), t803 (1), t2432 (1),
t2434 (1)
18 1 16 (89) 15 3
CC012 t012 (3), t021 (2), t093 (1),
t122 (2), t298 (1), t665 (1),
t913 (1), t1306 (1), t1836(1),
t2437 (1)
14 1 8 13 (93) 1 (7.1) 11 3
CC002 t002 (7), t062 (2), t548 (2) 11 5 5 (45.5) 3 (27.3) 1 (9) 10 1
CC376 t359 (3), t376 (1), t1198 (1),
t1897 (2)
7 1 2 5 (71.4) 7 0
CC078 t056 (4), t078 (1), t258 (1) 6 2 1 (16.7) 4 2
CC005 t005 (1), t223 (1), t712 (1),
t790 (1), t902 (1), t2439 (1)
6 3 (50) 1 (16.7) 4 2
CC024 t008 (2), t024 (1), t190 (1) 4 1 (25) 4 0
CC888 t127 (1), t160 (1), t888 (1),
t2433 (1)
4 2 (50) 2 2
CC230 t230 (1), t550 (1), t571 (1) 3 1 3 (100) 1 (33.3) 1 2
Others a t015 (6), t026 (4), t136 (1),
t153 (1), t159 (1), t163 (1),
t216 (1), t330 (1), t350 (1),
t645 (1), t777 (1), t1662 (1),
t1992 (1), t2435 (1), t2438 (1),
t2441 (1), t2442 (1), t2443 (1),
t2476 (1),
28 1 3 1 21 (75) 22 6
Total 101 2 5 17 2 70 5 2 80 21
Previously published MSSA spa types are in italics [3, 8]. Empty cells denote a negative result
eta/etb exfoliative toxin A/B, etd exfoliative toxin D, PVL Panton-Valentine leukocidin toxin, R resistant, tst toxic shock syndrome toxin
a Includes strains that were not typeable, singleton, no founder or excluded from analysis (shorter than five repeats)
b Resistant to at least one of these antibiotic compounds: levofloxacin, ciprofloxacin, norfloxacin
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[t084 (8 strains), t002 (7), t015 (6), t026 (4), t056 (4), t012
(3), t359 (3), t008 (2), t021 (2), t062 (2)] accounted for
40.6% of all isolates. Comparing our MSSA spa types with
those deposited in the spa server for MRSA and MSSA
strains, t002 is the fourth most frequent spa type worldwide
among MSSA and MRSA isolates. t008, t015, t024, and
t084 correspond to the top ten spa types in this large
database (http://www.spaserver.ridom.de). Some of our spa
types are similar to those previously reported in MSSA
strains (Table 1, spa types in italics) [3, 8]. Genetic
diversity of our study isolates exceeded that of a previously
published study where 14 different spa types among 84
MSSA strains were detected [3]. A recent study from
France on MSSA bloodstream infections using pulsed-field
gel electrophoresis (PFGE) for genetic analysis showed a
small number of PFGE divisions among isolates and were
associated with epidemic phenomena in healthcare institu-
tions [9]. If spa typing or spa-CC data were analyzed by the
type of ward, no cluster with the same MSSA spa type at
the same time was observed. The findings of molecular
typing were supported by epidemiological data from
surveillance: there was no evidence for an outbreak
situation during the study period.
S. aureus produces a variety of extracellular toxins.
They are associated with abscesses, furunculosis, and
necroticing pneumonia or toxic shock syndrome [5, 6].
The tst gene was detected in 17% of cases, etd in 5%, PVL
and eta/etb each in 2%. One isolate carried both PVL and
etd (spa type t1198). Every etd-positive strain was
associated with a different spa type, 17 tst-positive strains
with 13 different types (4 strains of spa t002). In our
study, the percentage of tst gene-positive invasive MSSA
strains was comparable with MSSA strains from blood-
stream infections [9] but lower than in a collection of
MSSA strains mainly from sites other than blood [3]. All
toxin positive strains were isolated from blood cultures
except for two tst-positive strains (from soft tissue and a
joint biopsy).
In contrast to recent studies from France and Germany,
the antibiotic resistance rates (Table 1) of quinolones and
macrolides were low [3, 9]. However, 93% and 89% of spa-
CC012 and spa-CC084/CC085 were penicillin-resistant,
respectively. Only 5% of all strains were macrolide
resistant, not allowing meaningful interpretation. The
prevalence of methicillin-resistant S. aureus (MRSA) in
our institution is low [10]; only two invasive isolates of S.
aureus were found to be methicillin resistant and were
therefore excluded.
Nine of 65 spa types representing 26.7% of MSSA
strains were also represented in our local MRSA spa
database (t002, t008, t012, t015, t024, t026, t163, t230,
t548). This genetic similarity between MRSA and MSSA is
consistent with other reports [3, 8, 11]. However, these spa
types are also frequent types worldwide and therefore
importation of MRSA strains seems more likely than
acquisition of methicillin-resistance genes among the local
MSSA strain pool as suggested previously [8, 11]. But the
common genetic background among MSSA and MRSA
strains indicates a certain selective advantage regardless of
resistance and accessory virulence gene profile.
In conclusion, spa typing revealed a great genetic
diversity among invasive MSSA strains consecutively
isolated from primarily sterile sites without a predominant
spa type or spa-CC. Besides worldwide common spa types
and spa-CC, many rare and newly recognized spa types
were observed. There was no evidence for MSSA cross-
infections among patients. tst was the most frequent
virulence gene detected among MSSA isolates. Further
spa typing data on MSSA strains from other places would
allow a more comprehensive understanding of the genetic
background.
Acknowledgements This study was supported by the scientific
research fund of the University Hospital Basel.
References
1. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U
(2006) Course and outcome of Staphylococcus aureus bacterae-
mia: a retrospective analysis of 308 episodes in a Swiss tertiary-
care centre. Clin Microbiol Infect 12:345–352
2. Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N,
Bharadwa K, Tsui J, Perlroth J, Shay A, Tagudar G, Ibebuogu U,
Spellberg B (2007) Clinical and epidemiologic characteristics
cannot distinguish community-associated methicillin-resistant
Staphylococcus aureus infection from methicillin-susceptible S.
aureus infection: a prospective investigation. Clin Infect Dis
44:471–482
3. Layer F, Ghebremedhin B, Konig W, Konig B (2006) Heteroge-
neity of methicillin-susceptible Staphylococcus aureus strains at a
German University Hospital implicates the circulating-strain pool
as a potential source of emerging methicillin-resistant S. aureus
clones. J Clin Microbiol 44:2179–2185
4. Strommenger B, Kettlitz C, Weniger T, Harmsen D, Friedrich AW,
Witte W (2006) Assignment of Staphylococcus isolates to groups
by spa typing, SmaI macrorestriction analysis, and multilocus
sequence typing. J Clin Microbiol 44:2533–2540
5. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO,
Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of
Panton-Valentine leukocidin-producing Staphylococcus aureus in
primary skin infections and pneumonia. Clin Infect Dis 29:1128–
1132
6. Yamasaki O, Tristan A, Yamaguchi T, Sugai M, Lina G, Bes M,
Vandenesch F, Etienne J (2006) Distribution of the exfoliative
toxin D gene in clinical Staphylococcus aureus isolates in France.
Clin Microbiol Infect 12:585–588
7. Mehrotra M, Wang G, Johnson WM (2000) Multiplex PCR for
detection of genes for Staphylococcus aureus enterotoxins,
Eur J Clin Microbiol Infect Dis (2008) 27:623–626 625
exfoliative toxins, toxic shock syndrome toxin 1, and methicillin
resistance. J Clin Microbiol 38:1032–1035
8. Hallin M, Denis O, Deplano A, De Mendonca R, De Ryck R,
Rottiers S, Struelens MJ (2007) Genetic relatedness between
methicillin-susceptible and methicillin-resistant Staphylococcus
aureus: results of a national survey. J Antimicrob Chemother
59:465–472
9. van der Mee-Marquet N, Epinette C, Loyau J, Arnault L,
Domelier AS, Losfelt B, Girard N, Quentin R (2007) Staphylo-
coccus aureus strains isolated from bloodstream infections
changed significantly in 2006. J Clin Microbiol 45:851–857
10. Mertz D, Frei R, Jaussi B, Tietz A, Stebler C, Fluckiger U,
Widmer AF (2007) Throat swabs are necessary to reliably detect
carriers of Staphylococcus aureus. Clin Infect Dis 45:475–477
11. Aires de Sousa M, Conceicao T, Simas C, de Lencastre H (2005)
Comparison of genetic backgrounds of methicillin-resistant and -
susceptible Staphylococcus aureus isolates from Portuguese
hospitals and the community. J Clin Microbiol 43:5150–5157
626 Eur J Clin Microbiol Infect Dis (2008) 27:623–626
